How Do I Manage Hypertension in Patients with Advanced Chronic Kidney Disease Not on Dialysis? Perspectives from Clinical Practice.
Fiche du document
2021
- doi: 10.2147/VHRM.S292522
- issn: 1176-6344
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.2147/VHRM.S292522
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33442257
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1178-2048
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_688099EFB06D6
info:eu-repo/semantics/openAccess , CC BY-NC 4.0 , https://creativecommons.org/licenses/by-nc/4.0/
Sujets proches
Blood pressure, High Vascular hypertension High blood pressureCiter ce document
E. Polychronopoulou et al., « How Do I Manage Hypertension in Patients with Advanced Chronic Kidney Disease Not on Dialysis? Perspectives from Clinical Practice. », Serveur académique Lausannois, ID : 10.2147/VHRM.S292522
Métriques
Partage / Export
Résumé
In the general population, the prevalence of moderate and severe chronic kidney disease (CKD) is usually below 5% but this figure is often higher in specific groups of patients such as those with type 2 diabetes. Patients with advanced CKD (CKD stage 3b and 4) are at high or very high cardiovascular risk, and their risk of progressing towards end-stage kidney disease (CKD stage 5) and the need of renal replacement therapy are elevated. Hypertension is a major cause of poor cardiovascular and renal outcomes in severe CKD. Therefore, an adequate control of blood pressure (BP) is mandatory. However, normalizing BP is often challenging in these patients because the clinical management of hypertension in advanced CKD is not well defined and rarely supported by large randomized controlled trials. In the present review, we discuss the characteristics of hypertension in advanced CKD, excluding dialysis, and its management integrating data from recent clinical studies and a pragmatic approach enriched by a long-standing clinical experience.